Literature DB >> 24511882

Obesity and headache: Part II--potential mechanism and treatment considerations.

Nu Cindy Chai1, Dale S Bond, Abhay Moghekar, Ann I Scher, B Lee Peterlin.   

Abstract

Obesity and headache are both associated with a substantial personal and societal impact, and epidemiologic studies have consistently identified a positive association between obesity and headache in general, as well as obesity and migraine specifically (see part I). In the current manuscript, we will discuss the potential mechanisms for the migraine-obesity association, with a focus on the central and peripheral pathophysiological pathways which overlap between migraine and those modulating the drive to feed. We then discuss surgical, behavioral, and pharmacological treatment considerations for overweight and obese migraineurs as well as for those with idiopathic intracranial hypertension. We close by briefly discussing where future research may be headed in light of this data.
© 2014 American Headache Society.

Entities:  

Keywords:  body mass index; headache; migraine; obesity

Mesh:

Year:  2014        PMID: 24511882      PMCID: PMC3975621          DOI: 10.1111/head.12297

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  87 in total

Review 1.  Obesity and headache: part I--a systematic review of the epidemiology of obesity and headache.

Authors:  Nu Cindy Chai; Ann I Scher; Abhay Moghekar; Dale S Bond; B Lee Peterlin
Journal:  Headache       Date:  2014-02       Impact factor: 5.887

2.  Prospective analysis of factors related to migraine attacks: the PAMINA study.

Authors:  C Wöber; W Brannath; K Schmidt; M Kapitan; E Rudel; P Wessely; C Wöber-Bingöl
Journal:  Cephalalgia       Date:  2007-04       Impact factor: 6.292

3.  Immunological aspects in migraine: increase of IL-10 plasma levels during attack.

Authors:  I Munno; M Marinaro; A Bassi; M A Cassiano; V Causarano; V Centonze
Journal:  Headache       Date:  2001-09       Impact factor: 5.887

4.  Orexin 1 receptor activation attenuates neurogenic dural vasodilation in an animal model of trigeminovascular nociception.

Authors:  P R Holland; S Akerman; P J Goadsby
Journal:  J Pharmacol Exp Ther       Date:  2005-09-13       Impact factor: 4.030

5.  NXN-188, a selective nNOS inhibitor and a 5-HT1B/1D receptor agonist, inhibits CGRP release in preclinical migraine models.

Authors:  Deepak K Bhatt; Saurabh Gupta; Inger Jansen-Olesen; John S Andrews; Jes Olesen
Journal:  Cephalalgia       Date:  2012-11-15       Impact factor: 6.292

6.  A study to evaluate the feasibility of an aerobic exercise program in patients with migraine.

Authors:  Emma Varkey; Asa Cider; Jane Carlsson; Mattias Linde
Journal:  Headache       Date:  2008-09-09       Impact factor: 5.887

7.  Aerobic exercise with relaxation: influence on pain and psychological well-being in female migraine patients.

Authors:  Sara Maria Dittrich; Verena Günther; Gerhard Franz; Martin Burtscher; Bernhard Holzner; Martin Kopp
Journal:  Clin J Sport Med       Date:  2008-07       Impact factor: 3.638

8.  Activation of nuclear factor-kappaB by high molecular weight and globular adiponectin.

Authors:  Fred Haugen; Christian A Drevon
Journal:  Endocrinology       Date:  2007-08-16       Impact factor: 4.736

9.  Effectiveness of multidisciplinary intervention in the treatment of migraine: a randomized clinical trial.

Authors:  Mark Lemstra; Brad Stewart; W P Olszynski
Journal:  Headache       Date:  2002-10       Impact factor: 5.887

10.  Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women.

Authors:  Miyao Matsubara; Shoji Maruoka; Shinji Katayose
Journal:  Eur J Endocrinol       Date:  2002-08       Impact factor: 6.664

View more
  24 in total

1.  Body composition status and the risk of migraine: A meta-analysis.

Authors:  Bizu Gelaye; Simona Sacco; Wendy J Brown; Haley L Nitchie; Raffaele Ornello; B Lee Peterlin
Journal:  Neurology       Date:  2017-04-12       Impact factor: 9.910

Review 2.  Part 2: Bypassing TBI-Metabolic Surgery and the Link Between Obesity and Traumatic Brain Injury-A Review.

Authors:  T W McGlennon; J N Buchwald; Walter J Pories; Fang Yu; Arthur Roberts; Eric P Ahnfeldt; Rukmini Menon; Henry Buchwald
Journal:  Obes Surg       Date:  2021-01-06       Impact factor: 4.129

Review 3.  Association Between Obesity and Migraine in Women.

Authors:  Jelena M Pavlovic; Julio R Vieira; Richard B Lipton; Dale S Bond
Journal:  Curr Pain Headache Rep       Date:  2017-08-25

4.  Dietary intake patterns and diet quality in a nationally representative sample of women with and without severe headache or migraine.

Authors:  E Whitney Evans; Richard B Lipton; B Lee Peterlin; Hollie A Raynor; J Graham Thomas; Kevin C O'Leary; Jelena Pavlovic; Rena R Wing; Dale S Bond
Journal:  Headache       Date:  2015-03-11       Impact factor: 5.887

5.  Ictal adipokines are associated with pain severity and treatment response in episodic migraine.

Authors:  Nu Cindy Chai; Bizu Gelaye; Gretchen E Tietjen; Paul D Dash; Barbara A Gower; Linda W White; Thomas N Ward; Ann I Scher; B Lee Peterlin
Journal:  Neurology       Date:  2015-03-06       Impact factor: 9.910

Review 6.  Biofeedback and behavioral treatments: filling some gaps.

Authors:  Frank Andrasik; Licia Grazzi
Journal:  Neurol Sci       Date:  2014-05       Impact factor: 3.307

Review 7.  Adipokines and Migraine: A Systematic Review.

Authors:  B Lee Peterlin; Simona Sacco; Claudia Bernecker; Ann I Scher
Journal:  Headache       Date:  2016-03-25       Impact factor: 5.887

Review 8.  Behavioral Weight Loss Treatments for Individuals with Migraine and Obesity.

Authors:  Cynthia Cervoni; Dale S Bond; Elizabeth K Seng
Journal:  Curr Pain Headache Rep       Date:  2016-02

Review 9.  Obesity and Migraine in Childhood.

Authors:  Tal Eidlitz Markus; Irene Toldo
Journal:  Curr Pain Headache Rep       Date:  2018-05-03

Review 10.  Bypassing TBI: Metabolic Surgery and the Link between Obesity and Traumatic Brain Injury-a Review.

Authors:  T W McGlennon; J N Buchwald; Walter J Pories; Fang Yu; Arthur Roberts; Eric P Ahnfeldt; Rukmini Menon; Henry Buchwald
Journal:  Obes Surg       Date:  2020-10-30       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.